121 related articles for article (PubMed ID: 1665953)
21. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
Bodey B; Psenko V; Lipsey AL; Kaiser HE
Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
[TBL] [Abstract][Full Text] [Related]
22. [Levels of soluble intracellular adhesion molecules 1 (sICAM-1) , soluble receptors for interleukin 2 (sIL-2R) and anti-Epstein-Barr viral capsid antigen (anti-VCA IgM) in blood serum during the course of infectious mononucleosis].
Tomasiewicz K; Modrzewska R; Łyczak A; Lis J
Wiad Lek; 2001; 54(3-4):171-8. PubMed ID: 11436683
[TBL] [Abstract][Full Text] [Related]
23. Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis.
Yoneyama A; Nakahara K; Higashihara M; Kurokawa K
Br J Haematol; 1995 Jan; 89(1):47-54. PubMed ID: 7833276
[TBL] [Abstract][Full Text] [Related]
24. [Serum level of soluble interleukin-2 receptor and T-lymphocyte subpopulations in normal pregnancy].
Liu CL; Xu HY; Liu Y
Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):518-20, 572. PubMed ID: 7835125
[TBL] [Abstract][Full Text] [Related]
25. Preferential expression of IL-2 receptor subunits on memory populations within CD4+ and CD8+ T cells.
Taga K; Kasahara Y; Yachie A; Miyawaki T; Taniguchi N
Immunology; 1991 Jan; 72(1):15-9. PubMed ID: 1900055
[TBL] [Abstract][Full Text] [Related]
26. Activated lymphocytes during acute Epstein-Barr virus infection.
Tomkinson BE; Wagner DK; Nelson DL; Sullivan JL
J Immunol; 1987 Dec; 139(11):3802-7. PubMed ID: 3119718
[TBL] [Abstract][Full Text] [Related]
27. Center for Disease Control (CDC) flow cytometry panel for human immunodeficiency virus infection allows recognition of infectious mononucleosis caused by Epstein-Barr virus or cytomegalovirus.
Zidovec Lepej S; Vince A; Rakusic S; Dakovic Rode O; Sonicki Z; Jeren T
Croat Med J; 2003 Dec; 44(6):702-6. PubMed ID: 14652882
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte activation after non-thermal trauma.
Walsh DS; Siritongtaworn P; Pattanapanyasat K; Thavichaigarn P; Kongcharoen P; Jiarakul N; Tongtawe P; Yongvanitchit K; Komoltri C; Dheeradhada C; Pearce FC; Wiesmann WP; Webster HK
Br J Surg; 2000 Feb; 87(2):223-30. PubMed ID: 10671932
[TBL] [Abstract][Full Text] [Related]
29. [Serum soluble CD4 and CD8 levels in Kawasaki disease].
Motohashi T
Arerugi; 1992 Feb; 41(2 Pt 1):140-7. PubMed ID: 1567283
[TBL] [Abstract][Full Text] [Related]
30. Soluble interleukin-2 receptor monitoring during bacterial and viral infections in liver transplant recipients: a comparative evaluation.
Rossi SJ; Schroeder TJ; Muth KL; Hanto DW; Balistreri WF; Ryckman FC
Clin Transplant; 1994 Oct; 8(5):479-84. PubMed ID: 7819615
[TBL] [Abstract][Full Text] [Related]
31. [Study on the level of soluble interleukin-2 receptor, expression of membrane interleukin-2 receptor and T lymphocyte subpopulations in pulmonary tuberculosis].
Liu C; Teng Q; Xing S
Zhonghua Jie He He Hu Xi Za Zhi; 1996 Feb; 19(1):44-6. PubMed ID: 9275389
[TBL] [Abstract][Full Text] [Related]
32. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.
Pezzilli R; Billi P; Gullo L; Beltrandi E; Maldini M; Mancini R; Incorvaia L; Miglioli M
Digestion; 1994; 55(4):268-73. PubMed ID: 8063032
[TBL] [Abstract][Full Text] [Related]
33. Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis.
Lipnick RN; Sfikakis PP; Klipple GL; Tsokos GC
Clin Immunol Immunopathol; 1993 Jul; 68(1):64-7. PubMed ID: 8513595
[TBL] [Abstract][Full Text] [Related]
34. Serum CD4, CD8, and interleukin-2 receptor levels in childhood acute myeloid leukemia.
Pui CH; Schell MJ; Vodian MA; Kline S; Mirro J; Crist WM; Behm FG
Leukemia; 1991 Mar; 5(3):249-54. PubMed ID: 1901614
[TBL] [Abstract][Full Text] [Related]
35. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
[TBL] [Abstract][Full Text] [Related]
36. [Significance of changes of T lymphocytes subsets in children with infectious mononucleosis and the effects of different interventions].
Chen ZG; Li M; Ji JZ; Chen H; Chen YF; Chen FH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):118-20. PubMed ID: 20104753
[TBL] [Abstract][Full Text] [Related]
37. [Serum soluble CD2, CD4 and CD8 levels in infectious mononucleosis].
Motohashi T
Arerugi; 1993 Aug; 42(8):926-33. PubMed ID: 7902699
[TBL] [Abstract][Full Text] [Related]
38. Immune activation in measles.
Griffin DE; Ward BJ; Jauregui E; Johnson RT; Vaisberg A
N Engl J Med; 1989 Jun; 320(25):1667-72. PubMed ID: 2498661
[TBL] [Abstract][Full Text] [Related]
39. Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus.
Rinaldo CR; Black PH; Hirsch MS
J Infect Dis; 1977 Nov; 136(5):667-78. PubMed ID: 199675
[TBL] [Abstract][Full Text] [Related]
40. Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis.
Biglino A; Sinicco A; Forno B; Pollono AM; Sciandra M; Martini C; Pich P; Gioannini P
Clin Immunol Immunopathol; 1996 Jan; 78(1):61-9. PubMed ID: 8599886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
